This course was created by Dr. Carolynn Francavilla, MD, FOMA a family physician and obesity medicine specialist. It is designed to complement medical knowledge regarding obesity medicine for clinicians and offer a framework to apply obesity medicine clinically based on Dr. Francavilla’s nine years of practicing obesity medicine. The course consists of approximately 13 hours of content including intake, follow-up, and maintenance visit processes; modules on prescribing anti-obesity medications, nutrition counseling, exercising counseling, and behavior change counseling; a module on disordered eating; and a model on payment and logistics. Mock patient encounters are integrated to reinforce concepts. The toolkit is a 60 page file that includes intake forms, nutrition plans, and many handouts to supplement patient education on the topics of the course, as well as billing cheat sheet. This toolkit file may be used by the purchaser only, but can be modified and distributed to patients by the purchaser. There are no refunds of returns. The course will be available to purchaser for a minimum of 12 months from date of purchase.
The Obesity Medicine Start Up Course and Toolkit
Release date: 11/15/2021
Termination date: 11/15/2024
Review date: 11/15/2021
ACCME Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Colorado Medical Society and Green Mountain Partners for Health/Weight Care Consulting. The Colorado Medical Society is accredited by the ACCME to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Colorado Medical Society designates this internet enduring material activity for a maximum of 13 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Relevant Financial Relationships:
The planners, faculty, and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies.
Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.